Journals / art / 2014 / Cilt: 29 - Sayı: 4

İzotretinoin kullanımına bağlı iki taraflı sakroiliit ve polinöropati gelişen bir olgu

A case with bilateral sacroiliitis and polyneuropathy development due to ısotretinoin use

Journal
art
Pages
304–308
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we report a 25-year-old male case who developed demyelinating polyneuropathy and sacroiliitis after six months of isotretinoin use.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Isotretinoin is a vitamin A derivative used in acne treatment when standard treatment including systemic antibiotics fails.
📊
Key Findings & Data:Isotretinoin exerts its effects via retinoic acid receptors.
💡
Conclusion & Impact:In this article, we report a 25-year-old male case who developed demyelinating polyneuropathy and sacroiliitis after six months of isotretinoin use.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Isotretinoin is a vitamin A derivative used in acne treatment when standard treatment including systemic antibiotics fails. Isotretinoin exerts its effects via retinoic acid receptors. However, it often causes mucocutaneous, musculoskeletal, neurological, and ocular adverse effects. Most common musculoskeletal adverse effects include arthralgia and miyalgia. Rarely, seronegative sacroiliitis can be seen. Neurological adverse effects are generally related to central nervous system. In patients using isotretinoin, sensorial fibers are involved earlier than motor fibers in peripheral nervous system. This involvement is more prominent in sensorial nerves and myelin fibers at distal. In this article, we report a 25-year-old male case who developed demyelinating polyneuropathy and sacroiliitis after six months of isotretinoin use.

Özet

İzotretinoin, sistemik antibiyotik içeren standart tedaviye yanıtın olmadığı durumlarda akne tedavisinde kullanılan vitamin A türevi bir ilaçtır. İzotretinoin retinoik asit reseptörleri üzerinden etkili olur. Öte yandan, sıklıkla mukokütanöz, kas-iskelet sistemi, nörolojik ve oküler yan etkilere neden olur. Kas-iskelet sistemine ait en sık karşılaşılan yan etkiler artralji ve miyaljidir. Nadiren seronegatif sakroiliit görülür. Nörolojik yan etkiler sıklıkla merkezi sinir sistemiyle ilişkilidir. İzotretinoin kullanan hastalarda, periferik sinir sisteminde duysal lifler motor liflere göre daha erken tutulmaktadır. Bu tutulum distalde duysal sinirler ve miyelin liflerde daha belirgindir. Bu yazıda, altı ay izotretinoin kullanımı sonrası demyelinizan tip polinöropati ve sakroiliit gelişen 25 yaşında bir erkek olgu sunuldu.

🔖

Cite This Article

ÇAKIR, T., BİLGİLİ, A., ÜLKER, R. N., SUBAŞI, V., DEMİRDAL, Ü. S. (2014). İzotretinoin kullanımına bağlı iki taraflı sakroiliit ve polinöropati gelişen bir olgu. art, Cilt: 29 - Sayı: 4, 304–308. https://ajindex.com/articles/205009

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Seukeran DC, Cunliffe WJ. The treatment of acne fulminans: a review of 25 cases. Br J Dermatol 1999;141:307-9. Lehucher Ceyrac D. Acute arthritis after isotretinoin. Dermatology 1999;198:406-7.
  2. Eksioglu E, Oztekin F, Unlu E, Cakci A, Keyik B, Karadavut IK. Sacroiliitis and polyneuropathy during isotretinoin treatment. Clin Exp Dermatol 2008;33:122-4.
  3. Pritchard J, Appleton R, Howard R, Hughes RA. Guillain-Barré syndrome seen in users of isotretinoin. BMJ 2004;328:1537. Sarı A, Dinç E, Adıgüzel U, Yıldırım Ö, TalaT İ. İzotretinoin tedavisi alan hastalarda optik sinir fonksiyonlarının değerlendirilmesi. TOD Journal 2010;40:1-3
  4. Aydogan K, Karli N. Effects of oral isotretinoin therapy on peripheral nerve functions: a preliminary study. Clin Exp Dermatol 2007;32:81-4.
  5. Yoleri Ö, Öngen B, Şengül İ, Ölmez N, Memiş A, Eşmeli F. Gut hastalığı seyrinde görülen polinöropati. Arch Rheumatol 2005;20:43-6.
  6. Chroni E, Sakkis T, Georgiou S, Monastirli A, Pasmatzi E, Paschalis C, et al. Stiff-person syndrome associated with oral isotretinoin treatment. Neuromuscul Disord 2002;12:886-8.
  7. Danon Mj, Carpenter S, Weiss V, Garvin JS. Sensory neuropathy associated long-terme etretinate (ET) therapy. Neurology 1986;36(Suppl 1):321. Tsambaos D, Sakkis T, Chroni E, Koniavitou K, Monastirli A, Pasmatzi E, et al. Peripheral sensory neuropathy associated with short-term oral acitretin therapy. Skin Pharmacol Appl Skin Physiol 2003;16:46-9.
  8. Chroni E, Pasmatzi E, Monastirli A, Georgiou S, Katsoulas G, Polychronopoulos P, et al. Short-term oral isotretinoin therapy does not cause clinical or subclinical peripheral neuropathy. J Dermatolog Treat 2006;17:6-8.
  9. Canpolat F, İnce NE, Katragün E, Kandi B, Öztekin MF. İzotreotinin tedavisinin duysal sinirler üzerine etkileri: Elektromiyografik bulgular. Türkderm 2012;46:210-2.
  10. McCaffery P, Dräger UC. Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor. Cytokine Growth Factor Rev 2000;11:233-49.
  11. Le Coz CJ, Wasser P, Tranchant C, Cribier B, Heid E, Warter JM, et al. Abnormal central nervous conduction in long-term treatments with retinoids. Ann Dermatol Venereol 1996;123:795-9. [Abstract] Bachmeyer C, Charoud A, Turc Y, Callot V, Blum L, Aractingi S. Isotretinoin-induced bilateral sacroiliitis. Dermatology 2003;206:285-6. Elías LM, Gómez MI, Torrelo A, Boixeda JP, Ledo A. Acne fulminans and bilateral seronegative sacroiliitis triggered by isotretinoin. J Dermatol 1991;18:366-7.
  12. Dinçer Ü, Çakar E, Kıra